Nathan W. Cummins

Prime, Shock, and Kill: Priming CD4 T Cells from HIV Patients with a BCL-2 Antagonist before HIV Reactivation Reduces HIV Reservoir Size

Nathan W. Cummins, Amy M. Sainski, Haiming Dai et al. · Journal of Virology · 2016 · 102 citations · Full text

HIV Replication Alters the Composition of Extrinsic Pathway Coagulation Factors and Increases Thrombin Generation

Jason V. Baker, Kathleen E. Brummel‐Ziedins, Jacqueline Neuhaus et al. · Journal of the American Heart Association · 2013 · 72 citations · Full text

Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition

Nathan W. Cummins, Amy Sainski‐Nguyen, Sekar Natesampillai et al. · Journal of Virology · 2017 · 72 citations · Full text

An advanced BLT-humanized mouse model for extended HIV-1 cure studies

Kerry J. Lavender, Craig S. Pace, Kathrin Sutter et al. · AIDS · 2017 · 71 citations · Full text

Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high‐risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin‐amphotericin combination therapies

Maheen Z. Abidi, M. Rizwan Sohail, Nathan W. Cummins et al. · Mycoses · 2014 · 68 citations

Invasive Mucormycosis, Echinocandin‐amphotericin Combination Therapies, Antifungal Agent +15